KIRSTY

biocon sdn.bhd🇨🇦 Health Canada

Approval Id: fa609f610f4fa9a4
Drug Approval Canada Name: KIRSTY
Product Name: KIRSTY
Status: Marketed
Status Date: 2024-04-04
Original Market Date: 2022-10-20
Din: 02520974
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Schedule D
Ahfs: 68:20.08
Atc Original: A10AB05 INSULIN ASPART
Atc Name: a 10 ab 05
Aig Number: 0144802001
Company Name: biocon sdn.bhd
Company Address: No. 1, Jalan Bioteknologi 1, Kawasan Perindustrian Silc, Iskandar Puteri, Johor, Malaysia, 79200

INSULIN ASPART

100 UNIT / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

fa609f610f4fa9a4

Type

Standard